Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.12 - $20.24 $340,848 - $968,929
-47,872 Reduced 96.43%
1,770 $36,000
Q2 2022

Aug 15, 2022

BUY
$5.1 - $10.0 $242,535 - $475,560
47,556 Added 2279.77%
49,642 $342,000
Q1 2022

May 16, 2022

SELL
$8.34 - $14.69 $37,163 - $65,458
-4,456 Reduced 68.11%
2,086 $19,000
Q4 2021

Feb 14, 2022

BUY
$13.6 - $24.89 $37,685 - $68,970
2,771 Added 73.48%
6,542 $93,000
Q3 2021

Nov 15, 2021

SELL
$21.22 - $25.7 $1.19 Million - $1.44 Million
-56,058 Reduced 93.7%
3,771 $88,000
Q2 2021

Aug 16, 2021

BUY
$22.86 - $30.95 $1.37 Million - $1.85 Million
59,829 New
59,829 $1.49 Million

Others Institutions Holding FMTX

About Forma Therapeutics Holdings, Inc.


  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.